Summary of Benefits of Industrial Membership in the CRP Consortium

Highlights

Cost: $25,000 per year starting January 2011 and for each continuing year of Membership; 180 day notice of withdrawal is required once Membership has been initiated. There is a special reduced rate of $5,000 for companies with less than 25 employees. This step was taken, with agreement of current Members, to expedite technology transfer to small start up organizations.

Paper Review: Yes, papers will be posted on web site before submission for publication

Meetings: Semi-annual: April and October

Right to Obtain a License for Patents on ATRP and CRP owned by CMU: Yes, a license will only be signed with an active Member.

Advisory Board Representative: Yes

Advise in Future Directions of CRP Research: Yes

Interact with Members of K. Matyjaszewski Group on Current Projects: Yes

Short-Term visit of Members Researcher to CMU laboratories: Yes

Support of Post-Doctoral Fellow: Yes, for additional $80K/year

Special Topics/Sponsored Research: CMU- with exlusive license in specific field of use for Sponsor.

IP Ownership: CMU—will continue to protect significant advances in all aspects of general research on CRP conducted within the Center for Macromolecular Engineering (licenses will be available to active Members of the Consortium)

Consortium members get an automatic license for the internal use of ATRP for non commercial use.

Special Topics/Sponsored Research: CMU—with exclusive license in specific field of use for Sponsor.

Past and present Members of the CRP Consortium include:

3M, Akzo Nobel, Asahi-Kasei, Atofina, ATRP Solutions, Bayer, Boston Scientific Corporation, BYK Chemie, Cabot Corporation, Centro de Investigación en Polimeros, Ciba Specialty Chemicals, Ciba Vision, Ciba Vision Novartis, DIC, Degussa (RohMax Additives), Dionex, DSM, Encapson, Evonik (Degussa RohMax Additives), GE, GIRSA Corporativo SA de CV, Headwaters Technology, Henkel, Kaneka Corporation, Lion Corp., Mitsubishi Chemical, Mitsui Chemicals, Inc., Motorola, Nalco Chemical Company, Nippon Gohsei, Nitto Denko, PPG, Rohner AG, Solvay, Sasol Technology, Teijin Limited, Warwick Effect Polymers, Zeon Chemicals, Aculon, Asahi Medical, BF Goodrich, BioHybrid Solutions, Entegris, Foshan Sheen Sun, Geon, JSR, Kilimanjaro Energy, Kuraray, LG Chem, Merck, Nanoderm, Rohm & Haas, Seeo, Silberline, Sinopec, Syngenta, and ThermoFisher.

See also: Objectives of the CRP Consortium
Research Contract Agreement (pdf file)
Term Sheet (pdf file).

For information concerning the Controlled/Living Radical Polymerizations (CRP) Consortium, contact:

James Spanswick
Associate Director,
Center for Macromolecular Engineering
Phone: (412) 268-9088 or (630) 690-5132
Fax: (412) 268-6897
jspan@andrew.cmu.edu